Literature DB >> 20075101

Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography.

H Goto1, K Ishii, T Uemura, N Miyamoto, T Yoshikawa, K Shimada, S Ohkawa.   

Abstract

BACKGROUND AND
PURPOSE: Diagnostic performance by MR imaging or by SPECT alone in discriminating DLB patients from AD patients has been estimated previously. However, the performance of a combination of MR imaging and SPECT has not yet been evaluated. Our aim was to evaluate the usefulness of combining MR imaging and SPECT to discriminate mild DLB from AD.
MATERIALS AND METHODS: Nineteen patients with mild DLB and 19 age- and cognitive decline-matched patients with mild AD underwent both SPECT and MR imaging. Hippocampal, occipital, and striatal volume and SPECT count ratios were compared. Linear discriminant and ROC analyses were performed by using the parameters of striatal volume and the occipital SPECT ratio.
RESULTS: The striatal volume ratio in the DLB group was significantly lower than that in the AD group. The occipital SPECT ratio in the DLB group was lower than that in the AD group. The mean area under the ROC curve from combined MR imaging and SPECT (AUC = 0.898) was higher than that from MR imaging (AUC = 0.679) or SPECT (AUC = 0.798) alone.
CONCLUSIONS: By combining MR imaging and SPECT, we were able to distinguish patients with mild DLB from those with AD with a high level of accuracy. Our findings suggest that combining MR imaging and SPECT modalities is a useful and practical approach for diagnostically differentiating DLB from AD.

Entities:  

Mesh:

Year:  2010        PMID: 20075101      PMCID: PMC7964226          DOI: 10.3174/ajnr.A1926

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  53 in total

1.  Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

Authors:  M A Piggott; E F Marshall; N Thomas; S Lloyd; J A Court; E Jaros; D Burn; M Johnson; R H Perry; I G McKeith; C Ballard; E K Perry
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.

Authors:  Sean J Colloby; E David Williams; David J Burn; Jim J Lloyd; Ian G McKeith; John T O'Brien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

3.  Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

Authors:  M Higuchi; M Tashiro; H Arai; N Okamura; S Hara; S Higuchi; M Itoh; R W Shin; J Q Trojanowski; H Sasaki
Journal:  Exp Neurol       Date:  2000-04       Impact factor: 5.330

4.  Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.

Authors:  R Barber; A Gholkar; P Scheltens; C Ballard; I G McKeith; J T O'Brien
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

5.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.

Authors:  Haruo Hanyu; Soichiro Shimizu; Kentaro Hirao; Hidekazu Kanetaka; Hirofumi Sakurai; Toshihiko Iwamoto; Kiyoshi Koizumi; Kimihiko Abe
Journal:  J Neurol Sci       Date:  2006-09-26       Impact factor: 3.181

6.  Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.

Authors:  S H Lisanby; W M McDonald; E W Massey; P M Doraiswamy; M Rozear; O B Boyko; K R Krishnan; C Nemeroff
Journal:  J Neural Transm Suppl       Date:  1993

7.  Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.

Authors:  Kazunari Ishii; Tsutomu Soma; Atsushi K Kono; Keitaro Sofue; Naokazu Miyamoto; Toshiki Yoshikawa; Etsuro Mori; Kenya Murase
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

8.  Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies.

Authors:  Kazunari Ishii; Kayo Hosaka; Tetsuya Mori; Etsuro Mori
Journal:  Ann Nucl Med       Date:  2004-07       Impact factor: 2.668

9.  Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.

Authors:  Jacques Pasquier; Bernard F Michel; Isabelle Brenot-Rossi; Nathalie Hassan-Sebbag; Richard Sauvan; Jean Louis Gastaut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-07-31       Impact factor: 9.236

10.  A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.

Authors:  Sean J Colloby; Michael J Firbank; Sanjeet Pakrasi; Jim J Lloyd; Ian Driver; Ian G McKeith; E David Williams; John T O'Brien
Journal:  Int Psychogeriatr       Date:  2008-08-27       Impact factor: 3.878

View more
  9 in total

1.  Perfusion Imaging with SPECT in the Era of Pathophysiology-Based Biomarkers for Alzheimer's Disease.

Authors:  Markus Weih; Umüt Degirmenci; Sebastian Kreil; Piotr Lewczuk; Daniela Schmidt; Johannes Kornhuber; Torsten Kuwert
Journal:  Int J Alzheimers Dis       Date:  2010-12-15

2.  Brain SPECT Imaging in Complex Psychiatric Cases: An Evidence-Based, Underutilized Tool.

Authors:  Daniel G Amen; Manuel Trujillo; Andrew Newberg; Kristen Willeumier; Robert Tarzwell; Joseph C Wu; Barry Chaitin
Journal:  Open Neuroimag J       Date:  2011-07-28

3.  Onset Patterns and Initial Symptoms of Dementia with Lewy Bodies: Possible Pathophysiological Diversities Deduced from a SPECT Study.

Authors:  T Fukui; K Hori; H Yoshimasu
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-08-05

4.  Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages.

Authors:  Daniel Roquet; Marion Sourty; Anne Botzung; Jean-Paul Armspach; Frédéric Blanc
Journal:  Alzheimers Res Ther       Date:  2016-07-12       Impact factor: 6.982

5.  Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study.

Authors:  E E Wolters; M van de Beek; R Ossenkoppele; S S V Golla; S C J Verfaillie; E M Coomans; T Timmers; D Visser; H Tuncel; F Barkhof; R Boellaard; A D Windhorst; W M van der Flier; Ph Scheltens; A W Lemstra; B N M van Berckel
Journal:  Neuroimage Clin       Date:  2020-11-19       Impact factor: 4.881

Review 6.  The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin
Journal:  Front Neurol       Date:  2022-03-28       Impact factor: 4.086

7.  Automatic volumetry of the cerebrospinal fluid space in idiopathic normal pressure hydrocephalus.

Authors:  Kazunari Ishii; Tsutomu Soma; Kenichi Shimada; Haruhiko Oda; Akira Terashima; Ryota Kawasaki
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-12-20

Review 8.  Neuroimaging characteristics of dementia with Lewy bodies.

Authors:  Elijah Mak; Li Su; Guy B Williams; John T O'Brien
Journal:  Alzheimers Res Ther       Date:  2014-04-09       Impact factor: 6.982

9.  A New Way Forward: How Brain SPECT Imaging Can Improve Outcomes and Transform Mental Health Care Into Brain Health Care.

Authors:  Daniel G Amen; Michael Easton
Journal:  Front Psychiatry       Date:  2021-12-10       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.